doValue S.p.A. (BIT:DOV)

Italy flag Italy · Delayed Price · Currency is EUR
2.328
-0.008 (-0.34%)
Apr 28, 2026, 5:35 PM CET
28.69%
Market Cap 441.51M
Revenue (ttm) 580.37M
Net Income (ttm) -8.22M
Shares Out 189.65M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 9.04
Dividend 0.09 (3.95%)
Ex-Dividend Date May 18, 2026
Volume 561,809
Average Volume 957,922
Open 2.320
Previous Close 2.336
Day's Range 2.280 - 2.340
52-Week Range 1.763 - 3.370
Beta 1.43
RSI 55.14
Earnings Date May 14, 2026

About doValue

doValue S.p.A. engages in the management of non-performing loans (NLP), unlikely to pay (UTP), early arrears, and performing loans for banks and investors in Italy, Spain, Greece, and Cyprus. The company offers NPL servicing, including administration, management, and recovery of loans utilizing in court and out-of-court recovery processes for and on behalf of third parties for portfolios mainly consisting in non-performing loans; and real estate servicing, such as real estate collateral management, real estate development, and property manageme... [Read more]

Sector Financials
Founded 2015
Employees 3,000
Stock Exchange Borsa Italiana
Ticker Symbol DOV
Full Company Profile

Financial Performance

Financial Statements

News

Dovalue SpA (FRA:1DB0) Q4 2025 Earnings Call Highlights: Strong Profitability and Strategic ...

Dovalue SpA (FRA:1DB0) Q4 2025 Earnings Call Highlights: Strong Profitability and Strategic M&A Drive Future Growth

2 months ago - GuruFocus

Preliminary Q4 2025 Dovalue SpA Earnings Call Transcript

Preliminary Q4 2025 Dovalue SpA Earnings Call Transcript

2 months ago - GuruFocus

doValue Earnings Call Transcript: Q4 2025

Met or exceeded all 2025 business plan targets, with strong revenue and EBITDA growth, robust cash flow, and successful M&A execution. Outlook for 2026 remains positive, with a strong pipeline, high dividend payout, and continued focus on technology and market expansion.

2 months ago - Transcripts

doValue Earnings Call Transcript: Q3 2025

Solid nine-month results with 29% revenue growth and 43% EBITDA ex NRI increase, driven by non-NPL revenue and successful integration of Gardant. New business intake surpassed targets, and a EUR 350 million bond issuance secured future financing.

5 months ago - Transcripts

doValue Earnings Call Transcript: Q2 2025

Record H1 results with 32% revenue growth, 47% EBITDA increase, and strong cash flow. Non-NPL and value-added services drove diversification, while the coeo acquisition is set to further enhance digital capabilities and growth. Guidance and leverage targets reaffirmed.

9 months ago - Transcripts

doValue Transcript: M&A Announcement

The acquisition of Queria is a transformative, strategic move to diversify and digitize the business, expanding into high-growth sectors and geographies. The €350 million deal, with additional earnout, is expected to deliver strong EPS accretion, enhanced resilience, and significant long-term growth, with minimal integration risk and a committed management team.

10 months ago - Transcripts

doValue Earnings Call Transcript: Q1 2025

Q1 2025 saw strong revenue and EBITDA growth, improved cash generation, and successful Gardant integration. New business targets were raised, leverage decreased, and value-added services expanded, with positive outlook and guidance reaffirmed.

1 year ago - Transcripts

doValue Earnings Call Transcript: Q4 2024

Surpassed 2024 business and financial targets, integrating Garant and strengthening capital structure. EBITDA reached EUR 165 million, with strong cash flow and improved leverage. 2025 guidance anticipates further revenue and EBITDA growth, supported by ongoing synergies and market expansion.

1 year ago - Transcripts

doValue Earnings Call Transcript: Q3 2024

Achieved €8 billion GBV from new business ahead of schedule, with strong market share gains in Greece and Spain. EBITDA ex-NRI reached €96 million, and 2024 guidance is confirmed, supported by the Gardant acquisition and robust cost discipline.

1 year ago - Transcripts

doValue Earnings Call Transcript: Q2 2024

H1 2024 saw EBITDA exceed expectations at EUR 67 million, despite a 5.3% revenue drop year-over-year, with strong new business intake and robust cost discipline. The Gardant acquisition is on track for year-end, and full-year guidance was revised slightly lower due to delayed disposals.

1 year ago - Transcripts

doValue Transcript: CMD 2024

2 years ago - Transcripts

doValue Transcript: CMD 2022

4 years ago - Transcripts